Pennington, NJ, United States of America

Honghe Wan

USPTO Granted Patents = 9 


 

Average Co-Inventor Count = 5.2

ph-index = 4

Forward Citations = 55(Granted Patents)


Location History:

  • Princeton, NJ (US) (2017)
  • Pennington, NJ (US) (2009 - 2022)

Company Filing History:


Years Active: 2009-2022

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Honghe Wan

Introduction

Honghe Wan is a notable inventor based in Pennington, NJ (US), recognized for his significant contributions to the field of pharmaceutical sciences. With a total of 9 patents to his name, Wan has made strides in developing compounds that target critical biological pathways.

Latest Patents

Among his latest patents, Wan has developed macrocyclic toll-like receptor 7 (TLR7) agonists. These compounds are designed to modulate TLR7 activity, offering potential treatments for various conditions that can benefit from such modulation. Another significant invention is related to prodrugs of imidazotriazine compounds as CK2 inhibitors. This invention provides pharmaceutically active compounds that inhibit CK2 protein kinase activity, making them useful for treating cancer, psoriasis, and rheumatoid arthritis.

Career Highlights

Throughout his career, Wan has worked with prominent companies, including Bristol-Myers Squibb Company. His work in these organizations has allowed him to contribute to groundbreaking research and development in the pharmaceutical industry.

Collaborations

Wan has collaborated with esteemed colleagues such as Ashok Vinayak Purandare and Amy C. Hart, further enhancing the impact of his work through teamwork and shared expertise.

Conclusion

Honghe Wan's innovative contributions to pharmaceutical sciences demonstrate his commitment to advancing medical treatments through his inventions. His work continues to influence the field and offers hope for various medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…